Share-based Payment Arrangement, Expense of HOOKIPA Pharma Inc. from 31 Dec 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
HOOKIPA Pharma Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
  • HOOKIPA Pharma Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $353,000, a 42% decline year-over-year.
  • HOOKIPA Pharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $1,910,000, a 33% increase year-over-year.
  • HOOKIPA Pharma Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2,014,000, a 14% decline from 2023.
  • HOOKIPA Pharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2,345,000, a 54% decline from 2022.
  • HOOKIPA Pharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5,043,000, a 34% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

HOOKIPA Pharma Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,910,000 $353,000 -$104,000 -42% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $2,014,000 $865,000 +$448,000 +107% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
Q3 2024 $1,566,000 $939,000 +$365,000 +64% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $1,201,000 $459,000 -$237,000 -34% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,438,000 $249,000 -$907,000 -138% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $2,345,000 $417,000 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $574,000 -$466,000 -45% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $696,000 -$685,000 -50% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $658,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $1,040,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,381,000 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2

HOOKIPA Pharma Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,014,000 -$331,000 -14% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
2023 $2,345,000 -$2,698,000 -54% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
2022 $5,043,000 -$2,601,000 -34% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $7,644,000 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.